Ginkgo reaffirmed 2026 cash burn guidance and outlined first pharma autonomous lab sale to Novo Nordisk.
Why it matters
Ginkgo reaffirmed 2026 cash burn guidance and outlined first pharma autonomous lab sale to Novo Nordisk. — impact context not separately stored; see What changed.